Breaking into the Chinese medtech market
This article was originally published in Clinica
China is a big market, both in terms of its number of consumers and its vast physical size. But what sort of business environment exists in the country? And how do medtech firms even begin to think about making their mark in a country with an area of around 9.6 million sq km? Joseph Harvey asks two non-Chinese companies, Axis-Shield and Aircraft Medical, what progress they have made so far in building a medtech sales network in China
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals